Advertisement

Deepak Sapra takes charge as CEO of Gland Pharma Limited

Deepak Sapra takes charge as CEO of Gland Pharma Limited Leadership



Deepak Sapra has joined Gland Pharma Limited as Chief Executive Officer, effective November 16, 2026. He brings 27 years of executive experience, including more than 23 years in the pharmaceutical industry, with expertise across APIs, pharmaceutical services, global generics, business development and international operations.


Before joining Gland Pharma, Deepak served as CEO – API and Services at Dr. Reddy’s Laboratories, where he led an integrated business spanning generic pharmaceuticals, CDMO services, APIs, collaborations and global patient access. He also served on the Board of Aurigene Pharmaceutical Services Limited, a subsidiary of Dr. Reddy’s Laboratories.


During his tenure at Dr. Reddy’s, he held several senior leadership positions, including Senior Vice President and Global Business Head, and Vice President and Global Business Head. Earlier, he worked with Indian Railways as a Divisional Mechanical Engineer. He holds a postgraduate management qualification from the Indian Institute of Management Bangalore.


CXO TechBOT congratulates Deepak Sapra on his appointment as CEO of Gland Pharma Limited and wishes him success in leading the organisation's next phase of growth.